Title: ISAM Webinar: Time to revolutionize inhaler usage and provide better patient outcomes  

Monday, 21st November  2022, 8 am – 9 am (San Diego, CA); 11 am – 12 am (New York, NY); 5 pm – 6 pm (Paris, France)

Follow this link to register for the zoom webinar

Presenter: Professor Henry Chrystyn.

Henry Chrystyn is an Emeritus Professor at the University of Huddersfield 

Facilitators:

• Jessica Oakes
• Carsten Ehrhardt
• Barbara Rothen-Rutishauser (ISAM president)

Webinar content

The pressurised metered dose inhaler (pMDI) was introduced in 1956 and by the end of that year a report described the problems patients have using these inhalers. The first single dose dry powder inhaler (DPI) followed in 1967 and a multidose DPI in 1987. The drugs formulated in all the inhalers that are now available have revolutionised the management of patients but despite patient counselling sessions there are too many with inhaler technique and adherence problems leading to poor disease control. Electronic monitoring of how patients use their inhalers has the potential to provide objective information and feedback for self and clinical management. These electronic inhalers can measure inhalation parameters such as the peak inhalation flow (PIF), time to PIF, the duration of an inhalation and the inhaled volume so confirm that an inhalation was attempted. Hence, they monitor adherence, can give feedback about technique and disease deterioration if the parameters decline or rescue medicine use increases. This webinar will start with a review of past and present inhaler usage issues then describe how connected inhalers measuring inhalation parameters and attempted adherence, during real-life use, have the potential to individualise each patient’s management. 

About the presenter

• Henry Chrystyn is an Emeritus Professor and a past Fellow of the Royal Pharmaceutical Society of Great Britain. He registered as a pharmacist in 1973 and was appointed Professor of Clinical Pharmacy at the University of Bradford in 1992 before being appointed Professor and Head of Pharmacy at the University of Huddersfield in 2007.
• Professor Chrystyn has published over 250 original research articles involving inhalers and supervised 53 PhD students. He is internationally recognized for his research on inhaled therapies, which has a strong emphasis on how patients use inhalers, and the integration of pharmaceutical sciences with routine patient care.
• Professor Chrystyn was lead author of the ERS Consensus Statement on the use of inhalers published in the European Respiratory Journal in 2011. He was is a member of the inhaler devices section of the British Thoracic Society (BTS) and the Scottish Intercollegiate Guidelines Network (SIGN) Guidelines on the Management of Asthma and, until his retirement, he was an Executive Editor of the British Journal of Clinical Pharmacology for approximately 20 years. For the past 6 European Respiratory Society annual meetings he has presented an invited plenary lecture on the problems patients have using their inhalers.